Evidence Details for OSGIN2
Basic Information Top
| Gene Symbol: | OSGIN2 ( C8orf1,hT41 ) |
|---|---|
| Gene Full Name: | oxidative stress induced growth inhibitor family member 2 |
| Band: | 8q21.3 |
| Quick Links | Entrez ID:734; OMIM: 604598; Uniprot ID:OSGI2_HUMAN; ENSEMBL ID: ENSG00000164823; HGNC ID: 1355 |
| Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top>OSGIN2|734|nucleotide
ATGCCCGTGTGGTGCTGCCGCTGCTCCCTGGCCGGTCATTTCAGAAACTATAGTGACACTGAAACTGAAGGAGAGATTTTTAATTCCTTAGTGCAATACTTTGGT
GACAACTTGGGGCGAAAAGTTAAAGCGATGCCATTAGTTGAAGAAACTTCTTTACTGGAAGATTCGTCAGTGACTTTTCCTGTGGTAATAATAGGAAATGGACCC
TCAGGAATATGCCTTTCTTATATGTTATCAGGCTACAGACCGTATTTATCATCAGAAGCAATACACCCAAATACAATCTTAAATAGTAAATTAGAAGAAGCAAGA
CATCTTTCCATTGTTGATCAGGACTTAGAATACTTGTCTGAGGGCCTTGAGGGCCGATCATCCAATCCAGTTGCAGTACTTTTCGATACACTTCTTCATCCAGAT
GCTGACTTTGGGTATGATTATCCATCCGTTTTGCATTGGAAATTAGAGCAACATCATTATATCCCTCACGTAGTTCTTGGTAAAGGTCCACCTGGTGGGGCTTGG
CATAATATGGAAGGCTCCATGTTGACAATCAGCTTTGGAAGTTGGATGGAACTACCTGGACTTAAATTTAAGGACTGGGTATCAAGTAAACGAAGGAGCCTAAAA
GGGGATCGAGTTATGCCAGAGGAAATAGCTCGCTACTATAAACATTATGTAAAAGTCATGGGTCTTCAGAAGAATTTCAGAGAGAATACTTACATAACTTCCGTA
TCAAGACTCTACAGAGATCAAGATGATGATGATATTCAAGACAGAGATATTTCAACAAAGCATTTACAGATAGAGAAGTCAAACTTTATCAAGAGAAACTGGGAA
ATTAGGGGTTATCAGCGAATAGCTGATGGTTCTCATGTTCCCTTCTGCCTCTTTGCTGAGAATGTAGCGCTGGCAACTGGAACGCTGGATTCTCCTGCCCATCTG
GAAATTGAAGGGGAAGATTTTCCTTTTGTGTTTCATTCAATGCCTGAATTTGGAGCTGCTATAAACAAAGGAAAGTTGCGTGGCAAAGTGGATCCAGTGTTAATT
GTAGGTTCTGGGCTTACTGCCGCTGACGCAGTACTGTGTGCTTACAACAGTAATATCCCTGTGATTCATGTGTTTCGCAGACGAGTAACTGATCCAAGCTTAATT
Show »
ATGCCCGTGTGGTGCTGCCGCTGCTCCCTGGCCGGTCATTTCAGAAACTATAGTGACACTGAAACTGAAGGAGAGATTTTTAATTCCTTAGTGCAATACTTTGGT
GACAACTTGGGGCGAAAAGTTAAAGCGATGCCATTAGTTGAAGAAACTTCTTTACTGGAAGATTCGTCAGTGACTTTTCCTGTGGTAATAATAGGAAATGGACCC
TCAGGAATATGCCTTTCTTATATGTTATCAGGCTACAGACCGTATTTATCATCAGAAGCAATACACCCAAATACAATCTTAAATAGTAAATTAGAAGAAGCAAGA
CATCTTTCCATTGTTGATCAGGACTTAGAATACTTGTCTGAGGGCCTTGAGGGCCGATCATCCAATCCAGTTGCAGTACTTTTCGATACACTTCTTCATCCAGAT
GCTGACTTTGGGTATGATTATCCATCCGTTTTGCATTGGAAATTAGAGCAACATCATTATATCCCTCACGTAGTTCTTGGTAAAGGTCCACCTGGTGGGGCTTGG
CATAATATGGAAGGCTCCATGTTGACAATCAGCTTTGGAAGTTGGATGGAACTACCTGGACTTAAATTTAAGGACTGGGTATCAAGTAAACGAAGGAGCCTAAAA
GGGGATCGAGTTATGCCAGAGGAAATAGCTCGCTACTATAAACATTATGTAAAAGTCATGGGTCTTCAGAAGAATTTCAGAGAGAATACTTACATAACTTCCGTA
TCAAGACTCTACAGAGATCAAGATGATGATGATATTCAAGACAGAGATATTTCAACAAAGCATTTACAGATAGAGAAGTCAAACTTTATCAAGAGAAACTGGGAA
ATTAGGGGTTATCAGCGAATAGCTGATGGTTCTCATGTTCCCTTCTGCCTCTTTGCTGAGAATGTAGCGCTGGCAACTGGAACGCTGGATTCTCCTGCCCATCTG
GAAATTGAAGGGGAAGATTTTCCTTTTGTGTTTCATTCAATGCCTGAATTTGGAGCTGCTATAAACAAAGGAAAGTTGCGTGGCAAAGTGGATCCAGTGTTAATT
GTAGGTTCTGGGCTTACTGCCGCTGACGCAGTACTGTGTGCTTACAACAGTAATATCCCTGTGATTCATGTGTTTCGCAGACGAGTAACTGATCCAAGCTTAATT
Show »
>OSGIN2|734|protein
MPVWCCRCSLAGHFRNYSDTETEGEIFNSLVQYFGDNLGRKVKAMPLVEETSLLEDSSVTFPVVIIGNGPSGICLSYMLSGYRPYLSSEAIHPNTILNSKLEEAR
HLSIVDQDLEYLSEGLEGRSSNPVAVLFDTLLHPDADFGYDYPSVLHWKLEQHHYIPHVVLGKGPPGGAWHNMEGSMLTISFGSWMELPGLKFKDWVSSKRRSLK
GDRVMPEEIARYYKHYVKVMGLQKNFRENTYITSVSRLYRDQDDDDIQDRDISTKHLQIEKSNFIKRNWEIRGYQRIADGSHVPFCLFAENVALATGTLDSPAHL
EIEGEDFPFVFHSMPEFGAAINKGKLRGKVDPVLIVGSGLTAADAVLCAYNSNIPVIHVFRRRVTDPSLIFKQLPKKLYPEYHKVYHMMCTQSYSVDSNLLSDYT
SFPEHRVLSFKSDMKCVLQSVSGLKKIFKLSAAVVLIGSHPNLSFLKDQGCYLGHKSSQPITCKGNPVEIDTYTYECIKEANLFALGPLVGDNFVRFLKGGALGV
Show »
MPVWCCRCSLAGHFRNYSDTETEGEIFNSLVQYFGDNLGRKVKAMPLVEETSLLEDSSVTFPVVIIGNGPSGICLSYMLSGYRPYLSSEAIHPNTILNSKLEEAR
HLSIVDQDLEYLSEGLEGRSSNPVAVLFDTLLHPDADFGYDYPSVLHWKLEQHHYIPHVVLGKGPPGGAWHNMEGSMLTISFGSWMELPGLKFKDWVSSKRRSLK
GDRVMPEEIARYYKHYVKVMGLQKNFRENTYITSVSRLYRDQDDDDIQDRDISTKHLQIEKSNFIKRNWEIRGYQRIADGSHVPFCLFAENVALATGTLDSPAHL
EIEGEDFPFVFHSMPEFGAAINKGKLRGKVDPVLIVGSGLTAADAVLCAYNSNIPVIHVFRRRVTDPSLIFKQLPKKLYPEYHKVYHMMCTQSYSVDSNLLSDYT
SFPEHRVLSFKSDMKCVLQSVSGLKKIFKLSAAVVLIGSHPNLSFLKDQGCYLGHKSSQPITCKGNPVEIDTYTYECIKEANLFALGPLVGDNFVRFLKGGALGV
Show »
Evidence summary TopClick the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
| Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Score (No. of Studies) | No | 0 (1) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2) |
Syndromic Autism Gene TopGenome-Wide Association Studies (By Ethnic Group) Top Family Based Association Studies: 1
| Reference | Stage | Platform | #Families | Affecteds | Result | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ (range) |
||||||
| CAUCASIAN | |||||||||||
| Hussman, 2011_1 | Discovery | Illumina Infinium Human 1 M beadship | 597 | - (-) |  |  | ASD | - - |
- - | ||
Case Control Based Association Studies: 0
| Reference | Stage | Platform | ASD Cases | Normal Controls | Result | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ | #Subjects (% Women) |
Age (range) |
|||||
| No Evidence. | ||||||||||||
CNV Studies TopLinkage Studies TopLow Scale Association Studies (by Ethnic Group) TopLarge Scale Expression Studies Top Microarray Studies: 1
| Reference | Source | Tissue | #Subjects (% Women) |
ADI-R | ADOS | Endo- pheno | Diagnosis | Normal Controls (% Women) |
Fold Change | Up/ Down | P/Q value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hu, 2009_1 | mixed | lymphoblastoid cell lines | 21 (-) | | | autism with nonaffected sib pairs | autism | 17 (-) |
1.14 | Up | - | |
| ||||||||||||
Proteomics Studies:0
| Reference | Source | Tissue | Platform | #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Normal Controls(% Women) | |
|---|---|---|---|---|---|---|---|---|---|
| No Evidence. | |||||||||
NGS de novo Mutation Studies TopNGS Mosaic SNV Studies TopNGS Other Studies Top Low Scale Gene Studies TopContact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.